This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

LEWIS P. ROWLAND, MD; STANLEY FAHN, MD; ERICH HIRSCHBERG, PhD; DONALD H. HARTER, MD

Arch Neurol. 1964;10(6):537-562.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Human myoglobinuria has been regarded as a rare syndrome, but, as in other rare syndromes, increasing awareness has led to an increasing number of reports. The first description is usually attributed to Meyer-Betz in 1910,⁹⁶ and there have been about 118 cases in the world literature until the present, 103 since 1951 (Table 1).

The total of 118 is only an approximation because selection of cases has been somewhat arbitrary. On the one hand, the urinary pigment has not been strictly identified in all cases (although the clinical and pathological descriptions were felt to be compatible with the diagnosis). On the other hand, the compilation includes only those cases considered to be primarily "idiopathic," not those due to exogenous causes, but this distinction is not precise. Furthermore, some cases of probable myoglobinuria have been reported with other diagnoses and have not been included.^43,48,49 It is a major . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

Departments of Neurology and Biochemistry, College of Physicians and Surgeons, Columbia University; Neurological Clinical Research Center, Neurological Institute, Columbia-Presbyterian Medical Center, New York City, and Neurology Service, Department of Medicine, Wilford Hall USAF Hospital, Aerospace Medical Division (AFSC), Lackland Air Force Base, Texas.

Footnotes
Received for publication March 3, 1964; accepted March 17.

Associate Professor of Neurology, College of Physicians and Surgeons, Columbia University; Co-Director, Neurological Clinical Research Center, Neurological Institute (Dr. Rowland); formerly Assistant Resident in Neurology, Presbyterian Hospital, New York City; present address: National Institute of Neurological Diseases and Blindness, National Institutes of Health, Bethesda, Md (Dr. Fahn); Assistant Professor of Biochemistry, College of Physicians and Surgeons, Columbia University (Dr. Hirschberg); formerly Captain, USAF, MC, Wilford Hall USAF Hospital; present address: The Rockefeller Institute, New York City (Dr. Harter).

Supported by USPHS grants B-3359, B-3102, and CA-02332.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?